Loading insider details...
Latest Form 4 (Jul 29, 2026): Purchase of 95,398 OTLK shares, $100.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 95,398 | $100.0K |
| May 27, 2026 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 122,174 | $50.0K |
| Oct 3, 2025 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 286,734 | n/a |
| Feb 6, 2025 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 12,323 | n/a |
| Oct 4, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 56,636 | n/a |
| Mar 8, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 94,441 | n/a |
| Oct 5, 2023 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 372,671 | n/a |
| Mar 31, 2023 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 41,065 | n/a |
| Oct 11, 2022 | Outlook Therapeutics, Inc. (OTLK) | Purchase | 30,000 | $38.7K |
| Oct 7, 2022 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 74,878 | n/a |